COMMUNIQUÉS West-GlobeNewswire

CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine

24/05/2018 - 12:11

OSLO, Norway and BALTIMORE and GAITHERSBURG, Md., May 24, 2018 (GLOBE NEWSWIRE) -- CEPI—the Coalition for Epidemic Preparedness Innovations—today announced a collaboration with Profectus BioSciences, Inc. and Emergent [...]

BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference

24/05/2018 - 12:00

RESEARCH TRIANGLE PARK, N.C. and EXTON, Pa., May 24, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (“BioCryst”) (NASDAQ: BCRX ), and Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA ), today announced that [...]

PRA Named International Clinical Research Company of the Year

24/05/2018 - 10:00

RALEIGH, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH ) is pleased to announce it was recognized by PharmaTimes as the International Clinical Research Company of the Year. This is the [...]

Helsinn announces EUR6 million investment in Helsinn Birex Pharmaceuticals to safeguard the quality and authenticity of its products

24/05/2018 - 09:30

Helsinn announces EUR6 million investment in Helsinn Birex Pharmaceuticals to safeguard the quality and authenticity of its products Lugano, Switzerland, May 24, 2018 – Helsinn, a Swiss pharmaceutical group focused on [...]

Real-world evidence shows clinically meaningful weight loss in people receiving Saxenda®

24/05/2018 - 09:02

Vienna, Austria, 24 May 2018 - People treated with Saxenda ® (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with diet and exercise. [...]

Independent Stent Imaging Study Shows Excellent Healing Profile with Resolute Onyx DES in Complex Patients with Coronary Artery Disease

24/05/2018 - 08:31

Onyx 1-Month OCT Study Provides Potential Insights on DAPT Duration in Complex Patients Following Stent Implantation DUBLIN and PARIS- May 24, 2018 - Investigators today unveiled clinical data from the independently run [...]

Independent Stent Imaging Study Shows Excellent Healing Profile with Resolute Onyx DES in Complex Patients with Coronary Artery Disease

24/05/2018 - 08:31

Onyx 1-Month OCT Study Provides Potential Insights on DAPT Duration in Complex Patients Following Stent Implantation DUBLIN and PARIS- May 24, 2018 - Investigators today unveiled clinical data from the independently run [...]

Immunicum AB: Invitation to Investor Event

24/05/2018 - 08:00

Press Release 24 May 2018 Immunicum AB: Invitation to Investor Event Immunicum AB (publ; IMMU.ST) announced today that the Company will host an investor event in Kalmar on June 13 starting at 18:00 CEST. Carlos de Sousa [...]

Shire plc : Rule 2.9 Announcement

24/05/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 24 May 2018 Shire [...]

Saniona publishes its interim report for the first quarter 2018

24/05/2018 - 08:00

PRESS RELEASE May 24, 2018 Financial highlights Q1 2018 (Q1 2017) Net revenues were SEK 4.3 M (7.5 M) EBIT was SEK -15.7 M (-7.6 M) Net profit/loss was SEK -13.5 M (-6.4 M) Earnings per share were SEK -0.62 (-0.31) [...]

Bavarian Nordic Announces Interim Results for the First Three Months of 2018

24/05/2018 - 07:43

COPENHAGEN, Denmark, May 24, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business progress for the first three months of 2018. First quarter highlights and [...]

Sandoz receives European Commission approval for Zessly® (infliximab) in gastroenterological, rheumatological and dermatological diseases

24/05/2018 - 07:01

European Commission's (EC) approval based on comprehensive data package confirming that Zessly ® matches safety, efficacy and quality of reference medicine Biosimilars such as Zessly enable earlier patient access to [...]

Scholar Rock Announces Pricing of Initial Public Offering

24/05/2018 - 03:52

CAMBRIDGE, Mass., May 23, 2018 (GLOBE NEWSWIRE) -- Scholar Rock (NASDAQ: SRRK ), a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in [...]

Arcturus Therapeutics Comments on Court Ruling on Undisclosed Group Organized by Joseph E. Payne and his Associates in Violation of Regulation 13D

24/05/2018 - 03:45

California Federal Court Rules that Arcturus is Likely to Succeed on Merits of its Claims Against Payne Further Violations by Payne and His Associates Enjoined to Permit all Arcturus Shareholders to Have a Fully [...]

Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Initial Public Offering

24/05/2018 - 03:13

HAMILTON, Bermuda, May 23, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (“Kiniksa”) announced today the pricing of its initial public offering of 8,477,777 Class A common shares at a public offering price of $ [...]

Melinta Therapeutics Announces Pricing of Public Offering of Common Stock

24/05/2018 - 03:07

NEW HAVEN, Conn., May 23, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]

Allscripts to deliver anesthesia solution across SingHealth healthcare institutions

24/05/2018 - 02:00

SINGAPORE, May 23, 2018 (GLOBE NEWSWIRE) -- Singapore’s largest public healthcare group, SingHealth, has partnered with Allscripts (NASDAQ: MDRX ) to implement iPro Anesthesia across the Group. The advanced software [...]

Adventist Health Appoints Rick Rawson as President of Rideout Health

24/05/2018 - 00:16

MARYSVILLE, Calif., May 23, 2018 (GLOBE NEWSWIRE) -- Adventist Health announced today the appointment of Rick Rawson as the new president of Rideout Health, serving the Marysville and Yuba City communities. Rawson has [...]

Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demonstrating that Crysvita® (burosumab) Improved Outcomes in Children with X-linked Hypophosphatemia in the New England Journal of Medicine

23/05/2018 - 23:01

Pediatric Study Demonstrated Improvements in Rickets Severity, Growth, Pain and Physical Activity in Children with Debilitating, Lifelong Hereditary Disease NOVATO, Calif., TOKYO, JAPAN, and LONDON, May 23, 2018 (GLOBE [...]